Literature DB >> 29022134

The impact of smoking on disease activity, disability, and radiographic damage in rheumatoid arthritis: is cigarette protective?

Mario Andrés Quintana-Duque1, Federico Rondon-Herrera2, Enrique Calvo-Paramo3, Juan Jose Yunis4, Adriana Varela-Nariño5, Antonio Iglesias-Gamarra2.   

Abstract

The ojective of this study is to assess the effect of tobacco smoking on disease activity, functional ability, and joint damage in a cohort of patients with early onset rheumatoid arthritis (EORA). 129 EORA patients attending the Rheumatology Unit of the School of Medicine of the "Universidad Nacional de Colombia" and the "Clínica de Artritis y Rehabilitación" in Bogota, Colombia, were enrolled in a prospective observational cohort study with 3-year follow-up. Clinical, biological, immunogenetics, and radiographic data were analyzed. Active disease was defined as DAS28 > 2.6. Smoking status was assessed by self-report as "never smokers" and "ever smokers". Patient groups with different smoking status were compared for RA measures. Status as "never smokers" and "ever smokers" was reported by 81.3 and 18.7%. Ever smokers had less risk of disability (HAQ-DI ≥ 0.5) at 36 month (Ever smokers vs. Never smokers OR for HAQ ≥ 0.5 0.25, 95% CI 0.06-0.97, p = 0.04). When former smokers were excluded in analysis, we found that current smoking was also associated with less disability and less risk of active disease. The percentage of erosive disease, radiographic progression, and SvdH score were similar in all smoking categories. In Colombian patients with EORA, smoking was associated with less disease activity and disability. Radiographic joint damage progressed at an equivalent rate in smokers and non-smokers. These data suggest a more benign, or at least not deleterious clinical course in smokers with RA.

Entities:  

Keywords:  Disability; Disease activity; Early onset rheumatoid arthritis; Radiographic progression; Smoking

Mesh:

Substances:

Year:  2017        PMID: 29022134     DOI: 10.1007/s00296-017-3845-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group.

Authors:  G Westhoff; R Rau; A Zink
Journal:  Rheumatology (Oxford)       Date:  2008-04-04       Impact factor: 7.580

2.  The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis.

Authors:  F Wolfe
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

3.  Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.

Authors:  S P Linn-Rasker; A H M van der Helm-van Mil; F A van Gaalen; M Kloppenburg; R R P de Vries; S le Cessie; F C Breedveld; R E M Toes; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

4.  The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug.

Authors:  M K Söderlin; I F Petersson; P Geborek
Journal:  Scand J Rheumatol       Date:  2011-11-28       Impact factor: 3.641

5.  The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis.

Authors:  B J Harrison; A J Silman; N J Wiles; D G Scott; D P Symmons
Journal:  Arthritis Rheum       Date:  2001-02

6.  Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference.

Authors:  Karin Bruynesteyn; Désirée van der Heijde; Maarten Boers; Ariane Saudan; Paul Peloso; Harold Paulus; Harry Houben; Bridget Griffiths; John Edmonds; Barry Bresnihan; Annelies Boonen; Sjef van der Linden
Journal:  Arthritis Rheum       Date:  2002-04

7.  The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis.

Authors:  V F Manfredsdottir; T Vikingsdottir; T Jonsson; A J Geirsson; O Kjartansson; M Heimisdottir; S L Sigurdardottir; H Valdimarsson; A Vikingsson
Journal:  Rheumatology (Oxford)       Date:  2006-01-10       Impact factor: 7.580

8.  Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA.

Authors:  D Hutchinson; L Shepstone; R Moots; J T Lear; M P Lynch
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

Review 9.  Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies.

Authors:  D Sugiyama; K Nishimura; K Tamaki; G Tsuji; T Nakazawa; A Morinobu; S Kumagai
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

10.  Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

Authors:  Hong Wang; Man Yu; Mahendar Ochani; Carol Ann Amella; Mahira Tanovic; Seenu Susarla; Jian Hua Li; Haichao Wang; Huan Yang; Luis Ulloa; Yousef Al-Abed; Christopher J Czura; Kevin J Tracey
Journal:  Nature       Date:  2002-12-22       Impact factor: 49.962

View more
  4 in total

1.  The impact of smoking on disease measures in rheumatoid arthritis: the need for appropriate adjustment of time-varying confounding.

Authors:  Milena A Gianfrancesco; Jinoos Yazdany; Gabriela Schmajuk
Journal:  Rheumatol Int       Date:  2017-12-05       Impact factor: 2.631

Review 2.  Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Authors:  Maud Wieczorek; James Martin Gwinnutt; Maxime Ransay-Colle; Suzanne Mm Verstappen; Francis Guillemin; Andra Balanescu; Heike Bischoff-Ferrari; Annelies Boonen; Giulio Cavalli; Savia de Souza; Annette de Thurah; Thomas Ernst Dorner; Rikke Helene Moe; Polina Putrik; Javier Rodríguez-Carrio; Lucía Silva-Fernández; Tanja A Stamm; Karen Walker-Bone; Joep Welling; Mirjana Zlatkovic-Svenda
Journal:  RMD Open       Date:  2022-03

3.  Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis.

Authors:  Emil Rydell; Kristina Forslind; Jan-Åke Nilsson; Lennart T H Jacobsson; Carl Turesson
Journal:  Arthritis Res Ther       Date:  2018-05-02       Impact factor: 5.156

4.  Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study.

Authors:  Désirée van der Heijde; Patrick Durez; Georg Schett; Esperanza Naredo; Mikkel Østergaard; Gabriella Meszaros; Francesco De Leonardis; Inmaculada de la Torre; Pedro López-Romero; Douglas Schlichting; Eric Nantz; Roy Fleischmann
Journal:  Clin Rheumatol       Date:  2018-08-04       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.